NCT06302491 - A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 27, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions

β -Thalassemia

Interventions

DRUG

AND017 capsules

Administer AND017 capsules once per day (QD)

DRUG

AND017 Placebo

Administer AND017 matching placebo capsules once per day (QD)

Trial Locations (5)

NOT_YET_RECRUITING

Nanfang Hospital Southern Medical University, Guangzhou

RECRUITING

Maoming People's Hospital, Maoming

RECRUITING

Guangxi Medical University No.1 Affiliated Hospital, Nanning

RECRUITING

Liuzhou People's Hospital, Liuzhou

RECRUITING

Hainan General Hospital, Haikou